← Back to Search

Mobile MCG Device for Acute Coronary Syndrome

N/A
Recruiting
Research Sponsored by SB Technology, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presents to ED with symptoms of Acute Coronary Syndrome (ACS)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the procedure (mcg scan)
Awards & highlights

Study Summary

This trial will study if a mobile MCG device can give reliable data in an emergency room setting.

Who is the study for?
This trial is for individuals who arrive at the emergency department with symptoms of Acute Coronary Syndrome (ACS) and can give written consent. It's not for those with ST-Elevation Myocardial Infarction, Atrial Fibrillation, non-ischemic causes like trauma, or active thoracic metal implants.Check my eligibility
What is being tested?
The study is testing the use of a new mobile MCG (magnetocardiography) device in an emergency setting to see if it can collect good data without interfering with normal ED operations.See study design
What are the potential side effects?
Since this trial involves data collection using a non-invasive device rather than medication or invasive procedures, there are no expected side effects from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I went to the emergency room because I might be having a heart attack.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the procedure (mcg scan)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the procedure (mcg scan) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
% analyzable Sandbox MCG data
Secondary outcome measures
Characterization of scan results that may differentiate between high risk and low risk ACS patients
Sandbox MCG safety

Trial Design

1Treatment groups
Experimental Treatment
Group I: Sponsor MCG deviceExperimental Treatment1 Intervention
All participants will receive a scan from the Sponsor MCG device

Find a Location

Who is running the clinical trial?

SB Technology, Inc.Lead Sponsor
Kit Yee Au-Yeung, PhDStudy DirectorSB Technology, Inc.
~63 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top